Loading video...

Video Failed to Load

Go Home

DeSci isn’t about DISRUPTING science; it’s about ACCELERATING it. From funding biotech IP to real clinical trials, Bio Protocol is building for the long term. Paul Kohlhaas bio/acc explains why real-world assets matter more than hype cycles. Watch his full interview with Jorge | The Gaming Strategist below 👇

34,166 views • 8 months ago •via X (Twitter)

0 Comments

No comments available

Comments from the original post will appear here

Related Videos